Fingerprint
Dive into the research topics of 'A phase II study of cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, in patients with very high risk relapsed acute myeloid leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically